Unchained Labs-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Unchained Labs - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014140
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unchained Labs is a life science tools company which offers protein stability assessment products for biologics. Its product portfolio includes UNcle (biologics stability platform), HUNK (aggregation predictor), pUNk (protein sizing system), GRUNT (automated formulation preparation system), freeslate and freeslate jr (automated workflow solution). Unchained Labs optim technology platform is developed for various applications such as stability studies, lead candidate selection and optimization, pre-formulation studies, candidate formulation among others. It markets its products to biopharmaceutical companies and academic institutions internationally throughout the world. The company’s venture capital is backed by investment firms such as Canaan Partners, TPG biotech, Novo Ventures. Unchained Labs is headquartered in Pleasanton, California, the US.

Unchained Labs – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Unchained Labs, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Unchained Labs, Medical Devices Deals, 2011 to YTD 2017 8
Unchained Labs, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Unchained Labs, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 10
Venture Financing 11
Unchained Labs Raises USD13 Million in Series C Financing 11
Unchained Labs Raises USD25 Million in Series B Financing 12
Unchained Labs Raises Additional USD6 Million in Series A Venture Financing 13
Unchained Labs Raises USD25 Million in Series A Financing 14
Trinean Raises US$5 Million In Venture Financing 15
Partnerships 17
Caliper Life Sciences Enters Into Distribution Agreement With Trinean 17
Licensing Agreements 18
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 18
Acquisition 19
Unchained Labs Acquires Trinean 19
Unchained Labs Acquires Freeslate 20
Unchained Labs – Key Competitors 21
Unchained Labs – Key Employees 22
Unchained Labs – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Product News 25
Aug 01, 2016: Unchained Labs makes lab automation a no-brainer with freeslate and freeslate jr. 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Unchained Labs, Pharmaceuticals & Healthcare, Key Facts 2
Unchained Labs, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Unchained Labs, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Unchained Labs, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Unchained Labs, Medical Devices Deals, 2011 to YTD 2017 8
Unchained Labs, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Unchained Labs Acquires Optim Technology from Avacta for USD5 Million 10
Unchained Labs Raises USD13 Million in Series C Financing 11
Unchained Labs Raises USD25 Million in Series B Financing 12
Unchained Labs Raises Additional USD6 Million in Series A Venture Financing 13
Unchained Labs Raises USD25 Million in Series A Financing 14
Trinean Raises US$5 Million In Venture Financing 15
Caliper Life Sciences Enters Into Distribution Agreement With Trinean 17
Trinean Enters Into Licensing Agreement With Perkinelmer For Microfluidics Technology 18
Unchained Labs Acquires Trinean 19
Unchained Labs Acquires Freeslate 20
Unchained Labs, Key Competitors 21
Unchained Labs, Key Employees 22
Unchained Labs, Other Locations 23
Unchained Labs, Subsidiaries 23

★海外企業調査レポート[Unchained Labs-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SSA Marine, Inc.:企業の戦略・SWOT・財務分析
    SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report Summary SSA Marine, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Kuwait Energy Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Kuwait Energy Plc (Kuwait Energy) is an independent oil and gas company that carries out exploration, appraisal, development and production of hydrocarbons. The company operates wide range of oil and gas assets in Middle East and North Africa (MENA) region. It has assets across Egypt, Yemen, …
  • Eaton Corporation Plc (ETN):企業の財務・戦略的SWOT分析
    Eaton Corporation Plc (ETN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Qualcomm Incorporated (QCOM):企業の財務・戦略的SWOT分析
    Qualcomm Incorporated (QCOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Lipocine Inc (LPCN):企業の財務・戦略的SWOT分析
    Summary Lipocine Inc (Lipocine) operates as a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testoster …
  • Genpact Ltd:企業の戦略・SWOT・財務情報
    Genpact Ltd - Strategy, SWOT and Corporate Finance Report Summary Genpact Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • China Agri-Industries Holdings Ltd (606):企業の財務・戦略的SWOT分析
    China Agri-Industries Holdings Ltd (606) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Chesswood Group Limited (CHW):企業の財務・戦略的SWOT分析
    Chesswood Group Limited (CHW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Devoteam Sa:企業の戦略・SWOT・財務分析
    Devoteam Sa - Strategy, SWOT and Corporate Finance Report Summary Devoteam Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Showa Denko KK (4004):企業の財務・戦略的SWOT分析
    Showa Denko KK (4004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Keryx Biopharmaceuticals Inc (KERX)-製薬・医療分野:企業M&A・提携分析
    Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease. The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Au …
  • Seiko Optical Products Co Ltd:企業の戦略的SWOT分析
    Seiko Optical Products Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Cosucra Groupe Warcoing SA:戦略・SWOT・企業財務分析
    Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report Summary Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • NuVista Energy Ltd (NVA):企業の財務・戦略的SWOT分析
    Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian Sedimentary Basin which is located in West Central Alberta and Northeast British Columbia areas …
  • Shriram Transport Finance Company Ltd.:企業のM&A・事業提携・投資動向
    Shriram Transport Finance Company Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shriram Transport Finance Company Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Elephant Oil Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Elephant Oil Ltd (Elephant Oil) is an oil and gas company. The company provides services such as exploration and production of oil and natural gas. It provides its exploration services in the underexplored areas of West Africa. Elephant Oil holds interest in a production-sharing contract in …
  • Nanosphere Inc-医療機器分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • Thor Mining Plc (THR):企業の財務・戦略的SWOT分析
    Summary Thor Mining Plc (Thor Mining) is a mining and mineral exploration and development company. The company carries out acquisition, exploration and develops gold, tungsten and molybdenum properties. Its projects include Molyhil Tungsten and Molybdenum, Spring Hill Gold, Dundas Gold project, and …
  • HomeWorks Tri-County Electric Cooperative Inc:発電所・企業SWOT分析
    HomeWorks Tri-County Electric Cooperative Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, in …
  • The Save Mart Companies:企業の戦略・SWOT・財務情報
    The Save Mart Companies - Strategy, SWOT and Corporate Finance Report Summary The Save Mart Companies - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆